Skip to main content
Erschienen in: International Urology and Nephrology 10/2015

01.10.2015 | Urology - Original article

A population-based analysis of contemporary patterns of care in younger men (<60 years old) with localized prostate cancer

verfasst von: Andrew T. Wong, Joseph J. Safdieh, Justin Rineer, Joseph Weiner, David Schwartz, David Schreiber

Erschienen in: International Urology and Nephrology | Ausgabe 10/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To analyze patterns of care in younger patients (<60 years old) with localized prostate cancer and to identify factors associated with selection of therapy using a large, population-based database.

Methods

The Surveillance, Epidemiology, and End Results database was queried to identify men <60 years old diagnosed with localized prostate cancer between 2010 and 2011. Patients were determined to have undergone no active treatment, local therapy, radiation therapy (RT), or radical prostatectomy (RP). Univariate and multivariate logistic regression analyses were performed to identify factors associated with the use of definitive therapy.

Results

A total of 12,732 men were included in this analysis. For the entire cohort, 12.5 % received no definitive treatment, 61.6 % RP, 22.0 % RT, and 3.3 % RP with adjuvant RT. Among men with low-, intermediate-, and high-risk prostate cancer, 17.2, 7.1, and 15.9 %, respectively, received no definitive therapy. RP was the most common choice of definitive therapy, utilized in 74.6 % of patients. Adjuvant RT after RP was utilized in 16.2 % of cases with positive margin and/or pT3/pT4 disease. African-American race, single marital status, and Medicaid/no insurance were associated with a decreased likelihood of receiving definitive treatment.

Conclusions

A significant proportion of younger men diagnosed with localized prostate cancer, particularly with low- or high-risk disease, are not receiving definitive therapy. African-American men, uninsured men, and patients with Medicaid or no medical insurance are less likely to receive definitive treatment.
Literatur
2.
3.
Zurück zum Zitat Lin DW, Porter M, Montgomery B (2009) Treatment and survival outcomes in young men diagnosed with prostate cancer: a population-based cohort. Cancer 115:2863–2871PubMedCentralCrossRefPubMed Lin DW, Porter M, Montgomery B (2009) Treatment and survival outcomes in young men diagnosed with prostate cancer: a population-based cohort. Cancer 115:2863–2871PubMedCentralCrossRefPubMed
4.
5.
Zurück zum Zitat Daskivich TJ, Kang-Hsien F, Koyama T et al (2015) Prediction of long-term other-cause mortality in men with early-stage prostate cancer: results from the Prostate Cancer Outcomes Study. Urology 85:92–100CrossRefPubMed Daskivich TJ, Kang-Hsien F, Koyama T et al (2015) Prediction of long-term other-cause mortality in men with early-stage prostate cancer: results from the Prostate Cancer Outcomes Study. Urology 85:92–100CrossRefPubMed
6.
Zurück zum Zitat Klotz L, Vesprini D, Sethukavalan P et al (2015) Long-term follow-up of a large active surveillance cohort of patients with prostate cancer. J Clin Oncol 33:272–277CrossRefPubMed Klotz L, Vesprini D, Sethukavalan P et al (2015) Long-term follow-up of a large active surveillance cohort of patients with prostate cancer. J Clin Oncol 33:272–277CrossRefPubMed
7.
8.
9.
Zurück zum Zitat Tyldesley S, McKenzie MR, So AI (2012) Radical prostatectomy versus observation for prostate cancer. N Engl J Med 367:1468PubMed Tyldesley S, McKenzie MR, So AI (2012) Radical prostatectomy versus observation for prostate cancer. N Engl J Med 367:1468PubMed
10.
Zurück zum Zitat Elliot SP, Johnson DP, Jarosek SL et al (2012) Bias due to missing SEER data in D’Amico risk stratification of prostate cancer. J Urol 187:2026–2031CrossRef Elliot SP, Johnson DP, Jarosek SL et al (2012) Bias due to missing SEER data in D’Amico risk stratification of prostate cancer. J Urol 187:2026–2031CrossRef
11.
Zurück zum Zitat Mahmood U, Levy LB, Nguyen PL et al (2014) Current clinical presentation and treatment of localized prostate cancer in the United States. J Urol 192:1650–1656CrossRefPubMed Mahmood U, Levy LB, Nguyen PL et al (2014) Current clinical presentation and treatment of localized prostate cancer in the United States. J Urol 192:1650–1656CrossRefPubMed
12.
Zurück zum Zitat Schymura MJ, Kahn AR, German RR et al (2010) Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1). BMC Cancer 10:152PubMedCentralCrossRefPubMed Schymura MJ, Kahn AR, German RR et al (2010) Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1). BMC Cancer 10:152PubMedCentralCrossRefPubMed
13.
Zurück zum Zitat Tosoian JT, Trock BJ, Landis P et al (2011) Active surveillance program for prostate cancer: an update of the Johns Hopkins experience. J Clin Oncol 29:2185–2190CrossRefPubMed Tosoian JT, Trock BJ, Landis P et al (2011) Active surveillance program for prostate cancer: an update of the Johns Hopkins experience. J Clin Oncol 29:2185–2190CrossRefPubMed
14.
Zurück zum Zitat van den Bergh RC, Vasarainen H, van der Poel HG et al (2010) Short-term outcomes of the prospective multicentre ‘Prostate Cancer Research International: Active Surveillance’ study. BJU Int 105:956–962CrossRefPubMed van den Bergh RC, Vasarainen H, van der Poel HG et al (2010) Short-term outcomes of the prospective multicentre ‘Prostate Cancer Research International: Active Surveillance’ study. BJU Int 105:956–962CrossRefPubMed
15.
Zurück zum Zitat Mason MD, Parulekar WR, Sydes MR, et al. (2015) Final report of the Intergroup randomized study of combined androgen-deprivation therapy plus radiotherapy versus androgen-deprivation therapy alone in locally advanced prostate cancer. J Clin Oncol 33:2143–2150PubMedCentralCrossRefPubMed Mason MD, Parulekar WR, Sydes MR, et al. (2015) Final report of the Intergroup randomized study of combined androgen-deprivation therapy plus radiotherapy versus androgen-deprivation therapy alone in locally advanced prostate cancer. J Clin Oncol 33:2143–2150PubMedCentralCrossRefPubMed
16.
Zurück zum Zitat Widmark A, Klepp O, Solberg A et al (2009) Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial. Lancet 73:301–308CrossRef Widmark A, Klepp O, Solberg A et al (2009) Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial. Lancet 73:301–308CrossRef
17.
Zurück zum Zitat Lane JA, Donovan JL, Davis M et al (2014) Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial. Lancet Oncol 15:1109–1118CrossRefPubMed Lane JA, Donovan JL, Davis M et al (2014) Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial. Lancet Oncol 15:1109–1118CrossRefPubMed
18.
Zurück zum Zitat Mahal BA, Aizer AA, Ziehr DR et al (2014) Trends in disparate treatment of African American men with localized prostate cancer across National Comprehensive Cancer Network risk groups. Urology 84:286–292CrossRef Mahal BA, Aizer AA, Ziehr DR et al (2014) Trends in disparate treatment of African American men with localized prostate cancer across National Comprehensive Cancer Network risk groups. Urology 84:286–292CrossRef
19.
Zurück zum Zitat Mahal BA, Ziehr DR, Aizer AA et al (2014) Getting back to equal: the influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancer. Urol Oncol 32:1285–1291CrossRefPubMed Mahal BA, Ziehr DR, Aizer AA et al (2014) Getting back to equal: the influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancer. Urol Oncol 32:1285–1291CrossRefPubMed
20.
Zurück zum Zitat Aizer AA, Chen MH, McCarthy EP et al (2013) Marital status and survival in patients with cancer. J Clin Oncol 31:3869–3876CrossRefPubMed Aizer AA, Chen MH, McCarthy EP et al (2013) Marital status and survival in patients with cancer. J Clin Oncol 31:3869–3876CrossRefPubMed
21.
Zurück zum Zitat Denberg TD, Beaty BL, Kim FJ, Steiner JF (2005) Marriage and ethnicity predict treatment in localized prostate carcinoma. Cancer 103:1819–1825CrossRefPubMed Denberg TD, Beaty BL, Kim FJ, Steiner JF (2005) Marriage and ethnicity predict treatment in localized prostate carcinoma. Cancer 103:1819–1825CrossRefPubMed
22.
Zurück zum Zitat Valicenti RK, Thompson I Jr, Albertsen P et al (2013) Adjuvant and salvage radiation therapy after prostatectomy: American Society for Radiation Oncology/American Urological Association guidelines. Int J Radiat Oncol Biol Phys 86:822–828CrossRefPubMed Valicenti RK, Thompson I Jr, Albertsen P et al (2013) Adjuvant and salvage radiation therapy after prostatectomy: American Society for Radiation Oncology/American Urological Association guidelines. Int J Radiat Oncol Biol Phys 86:822–828CrossRefPubMed
23.
Zurück zum Zitat Schreiber D, Rineer J, Yu JB et al (2010) Analysis of pathologic extent of disease for clinically localized prostate cancer after radical prostatectomy and subsequent use of adjuvant radiation in a national cohort. Cancer 116:5757–5766CrossRefPubMed Schreiber D, Rineer J, Yu JB et al (2010) Analysis of pathologic extent of disease for clinically localized prostate cancer after radical prostatectomy and subsequent use of adjuvant radiation in a national cohort. Cancer 116:5757–5766CrossRefPubMed
24.
Zurück zum Zitat Kalbasi A, Swisher-McClure S, Mitra N et al (2014) Low rates of adjuvant radiation in patients with nonmetastatic prostate cancer with high-risk pathologic features. Cancer 120:3089–3096PubMedCentralCrossRefPubMed Kalbasi A, Swisher-McClure S, Mitra N et al (2014) Low rates of adjuvant radiation in patients with nonmetastatic prostate cancer with high-risk pathologic features. Cancer 120:3089–3096PubMedCentralCrossRefPubMed
Metadaten
Titel
A population-based analysis of contemporary patterns of care in younger men (<60 years old) with localized prostate cancer
verfasst von
Andrew T. Wong
Joseph J. Safdieh
Justin Rineer
Joseph Weiner
David Schwartz
David Schreiber
Publikationsdatum
01.10.2015
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 10/2015
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-015-1096-8

Weitere Artikel der Ausgabe 10/2015

International Urology and Nephrology 10/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.